News & Updates

Show Multimedia Only

HPV vaccine uptake remains low in SG despite improved awareness

Knowledge of human papillomavirus (HPV) vaccination has improved in Singapore following government efforts to enhance cervical cancer awareness through national campaigns and policy changes. However, this has not translated to an increase in vaccine acceptance rates, according to a study.

HPV vaccine uptake remains low in SG despite improved awareness

20 hours ago

Atopic dermatitis may inhibit growth in children, but dupilumab helps

a day ago

Children with atopic dermatitis (AD) are at greater risk of impaired linear growth, but treatment with dupilumab may lessen the risk, suggests a study.

Atopic dermatitis may inhibit growth in children, but dupilumab helps

a day ago

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

a day ago

Outcomes are similar among patients with moderate-to-severe psoriasis who continued treatment with ustekinumab and those who switched to BAT2206, a drug being developed as a biosimilar of ustekinumab, according to a study.

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

a day ago

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

16 Dec 2025 by

The combination of chemotherapy and anti-EGFR/BRAF therapy provides optimal survival benefits to patients with advanced BRAF-mutated colorectal cancer (CRC), according to a study.

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

16 Dec 2025

Rifaximin does not improve survival in severe cirrhosis

12 Dec 2025

Treatment with rifaximin appears to provide no benefits in terms of 12-month survival or incidence of complications of cirrhosis in patients with severe cirrhosis and low ascitic fluid protein levels, a recent study has shown.

Rifaximin does not improve survival in severe cirrhosis

12 Dec 2025

HCPs, patients willing to trade off OCS benefits to avoid side effects

12 Dec 2025 by

Both patients and healthcare professionals prefer treatment for asthma attacks that avoids the side effects of oral corticosteroids (OCS), and both are willing to trade off benefits, according to a study.

HCPs, patients willing to trade off OCS benefits to avoid side effects

12 Dec 2025

Continuous use of TNFi on the rise in pregnant women

11 Dec 2025

A trend toward increased continuous use of tumour necrosis factor inhibitors has been observed throughout gestation, which suggests growing confidence in the safety and effectiveness of this medication during pregnancy, reveals a study.

Continuous use of TNFi on the rise in pregnant women

11 Dec 2025

Antimicrobial use rises following TNFi initiation in PsA patients

10 Dec 2025

A recent study has noted a temporary increase in antimicrobial use following initiation of tumour necrosis factor inhibitor (TNFi) treatment, with no significant risk in serious infections, among patients with psoriatic arthritis (PsA).

Antimicrobial use rises following TNFi initiation in PsA patients

10 Dec 2025

Nirsevimab cuts RSV burden in newborns

10 Dec 2025 by

A retrospective study from Italy shows an association between nirsevimab prophylaxis and a lower risk of respiratory syncytial virus (RSV) hospitalizations and a milder disease course.

Nirsevimab cuts RSV burden in newborns

10 Dec 2025

Is it safe to take NSAIDs when using oral anticoagulants?

09 Dec 2025 by

The use of oral anticoagulants (OACs) with NSAIDs results in clinical outcomes like those of OAC monotherapy, a study has shown.

Is it safe to take NSAIDs when using oral anticoagulants?

09 Dec 2025

News & Updates

Filter by Specialty:

Specialty:

HPV vaccine uptake remains low in SG despite improved awareness

HPV vaccine uptake remains low in SG despite improved awareness

Atopic dermatitis may inhibit growth in children, but dupilumab helps

Atopic dermatitis may inhibit growth in children, but dupilumab helps

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

Ustekinumab biosimilar shows potential against moderate-to-severe psoriasis

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

Rifaximin does not improve survival in severe cirrhosis

Rifaximin does not improve survival in severe cirrhosis

HCPs, patients willing to trade off OCS benefits to avoid side effects

HCPs, patients willing to trade off OCS benefits to avoid side effects

Continuous use of TNFi on the rise in pregnant women

Continuous use of TNFi on the rise in pregnant women

Antimicrobial use rises following TNFi initiation in PsA patients

Antimicrobial use rises following TNFi initiation in PsA patients

Nirsevimab cuts RSV burden in newborns

Nirsevimab cuts RSV burden in newborns

Is it safe to take NSAIDs when using oral anticoagulants?

Is it safe to take NSAIDs when using oral anticoagulants?